新聞 September 21, 2020

Inside Drug Pricing | An Obamacare Repeal Could Be a Win-Win for GOP on Drug Pricing

Michael Park is quoted on Obamacare’s potential repeal and how it could impact funding for the Centers for Medicare & Medicaid Services.

This website uses cookies to improve functionality and performance. For more information, see our Privacy Statement. Additional details for California consumers can be found here.